Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors. 2000

S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
Department of Pharmaceutical Chemistry, Rutgers, The State University of Nerw Jersey, Piscataway 08854-8020, USA.

A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.

UI MeSH Term Description Entries
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D059004 Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE I. DNA Topoisomerase I Inhibitor,DNA Topoisomerase III Inhibitor,DNA Topoisomerase III Inhibitors,DNA Type 1 Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitors,Topoisomerase 1 Inhibitor,Topoisomerase 1 Inhibitors,Topoisomerase 3 Inhibitor,Topoisomerase 3 Inhibitors,Topoisomerase I Inhibitor,Topoisomerase III Inhibitor,Topoisomerase III Inhibitors,DNA Topoisomerase I Inhibitors,DNA Type 1 Topoisomerase Inhibitors,1 Inhibitor, Topoisomerase,3 Inhibitor, Topoisomerase,3 Inhibitors, Topoisomerase,I Inhibitor, Topoisomerase,III Inhibitor, Topoisomerase,III Inhibitors, Topoisomerase,Inhibitor, Topoisomerase 1,Inhibitor, Topoisomerase 3,Inhibitor, Topoisomerase I,Inhibitor, Topoisomerase III,Inhibitors, Topoisomerase 1,Inhibitors, Topoisomerase 3,Inhibitors, Topoisomerase I,Inhibitors, Topoisomerase III

Related Publications

S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
May 2009, Expert opinion on therapeutic patents,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
July 1999, Archiv der Pharmazie,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
January 2007, Acta biochimica Polonica,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
April 2015, Bioorganic chemistry,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
January 2013, Acta poloniae pharmaceutica,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
July 2003, Farmaco (Societa chimica italiana : 1989),
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
April 2004, Biochemical and biophysical research communications,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
January 2014, Biological & pharmaceutical bulletin,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
January 2010, Expert opinion on therapeutic patents,
S Jin, and J S Kim, and S P Sim, and A Liu, and D S Pilch, and L F Liu, and E J LaVoie
January 2008, Bioorganicheskaia khimiia,
Copied contents to your clipboard!